← Back to feed
TimesLIVE·September 8, 2026 at 2:26 PM

Pharmaceutical company Novartis has suffered setbacks involving two drugs, according to TimesLIVE, adding pressure on the company's drug development pipeline. The failures also increase scrutiny of chief executive Vas Narasimhan and his mergers-and-acquisitions strategy, which he has pursued to bolster the Swiss drugmaker's growth prospects.

AI summary. Verify with the original source.

Novartispharmaceuticalsdrug pipelineVas Narasimhanmergers and acquisitions

Read full story at TimesLIVE

Listen

Audio summaries is a Premium feature

Unlock audio summaries, audio summaries, AI chat, Wikipedia facts, and ad-free reading.

$3.99 / month · cancel anytime

Go Premium

Background facts

Wikipedia facts is a Premium feature

Unlock wikipedia facts, audio summaries, AI chat, Wikipedia facts, and ad-free reading.

$3.99 / month · cancel anytime

Go Premium

Sources

Similar stories